ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia.

Anouchka P Laurent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.